ENTITY
Pfizer Inc

Pfizer Inc (PFE US)

289
Analysis
Health CareUnited States
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
more
Refresh
bullishShionogi & Co
22 Jun 2018 18:30

Innovation to Help Maintain HIV Franchise Market Share and Weather Harsh Domestic Market Conditions

Continuous innovation at HIV Franchise to not only help defend market share…. Concerns about competition from Gilead Sciences Inc (GILD US)'s,...

12 Jun 2018 15:33

Sector Capsule: Pet Products in Thailand

Pet products in Thailand registered value growth of 14% in current value terms to reach THB2.6 billion in 2017. Pet humanisation is the driving...

12 Apr 2018 23:44

A Conversation with Biogen

Biogen Inc (BIIB US) is Samsung Biologics Co., Ltd (207940 KS) 's minority (5.4%) partner in the Samsung Bioepis JV that manufactures and sells...

Share
bearishBiogen Inc
15 Mar 2018 22:36

Standing Alone in the Ampakines Pipeline: Biogen Sees Potential in Pfizer's Neuropsychiatry Asset

On 12 March 2018, Biogen Inc (BIIB US) announced an agreement to acquire Pfizer Inc (PFE US)'s first-in-class, Phase 2b ready AMPA receptor...

Logo
197 Views
Share
01 Mar 2018 08:44

Will Actinogen Ace Alzheimer's?

Alzheimer’s disease is an incurable neurodegenerative disorder that robs the affected individuals of memory, self-care and quality of life,...

Logo
215 Views
Share
x